ÂÜÀòÂÒÂ×

Simon Douglas is a seasoned leader in the biotechnology and healthcare sectors, currently serving as Non Executive Chairman at Abselion since November 2021 and Fusion Antibodies plc since 2006. With a background in developing innovative laboratory instruments at Abselion and spearheading antibody discovery services at Fusion Antibodies, Douglas also holds the position of Chief Executive at C Major Medical, specializing in patented auto-retracting needle technology. Previous roles include Non Executive Chairman at Cambridge Nutritional Sciences, Chief Executive at Biofortuna, and various leadership roles at Lab 901, Invitrogen, and DRI. Douglas earned an MPhil and PhD in Antibody Imaging of Tumours, along with a BSc in Chemistry from the University of Southampton.